Daniel Erik Abbott

17PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesMedical mycologyOptical fibre communication systems and technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 11, 2026
Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer.

Dustin A Deming, Sean G Kraus, Joshua Brand

|Aug 21, 2024
Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional analysis.

Haleh Amirian, Erin Dickey, Ifeanyichukwu Ogobuiro

|Jul 31, 2024
Understanding futility in pancreaticoduodenectomy: Insights from a national cohort.

Clayton T Marcinak, Kaleem S Ahmed, Noelle K LoConte

|Dec 05, 2022
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.

Boateng Kubi, Richard Nudotor, Nadege Fackche

|Jan 13, 2022
Reply: Comparing analgesic efficacy of peripheral nerve blocks with thoracic epidural block after major abdominal cancer surgery: Study design is important.

Taylor J Aiken, Daniel E Abbott

|Oct 07, 2021
Peripheral nerve blocks with liposomal bupivacaine are associated with increased opioid use compared to thoracic epidural in patients with an epigastric incision.

Taylor J Aiken, Elena Padilla, Deborah Lemaster

Pageof 3

Frequent Collaborators

3 joint publications

Timothy Michael Pawlik

3 joint publications

Kenneth Cardona

3 joint publications

James R Barrett

3 joint publications

Callisia N Clarke